Showing 21 - 40 results of 408 for search '"HPV"', query time: 0.06s Refine Results
  1. 21
  2. 22
  3. 23

    HPV vaccination and Native Americans: protocol for a systematic review of factors associated with HPV vaccine uptake among American Indians and Alaska Natives in the USA by Sameer Vali Gopalani, Ami E Sedani, Amanda E Janitz, Shari C Clifton, Julie Stoner, Jennifer Peck, Ashley Comiford, Alicia L Salvatore, Janis Campbell

    Published 2020-09-01
    “…Introduction The nine-valent human papillomavirus (HPV) vaccine could prevent an estimated 92% of the cancers attributable to HPV types targeted by the vaccine. …”
    Get full text
    Article
  4. 24

    Extended HPV genotyping by the BD Onclarity assay: concordance with screening HPV-DNA assays, triage biomarkers, and histopathology in women from the NTCC2 study by Laura De Marco, Simonetta Bisanzi, Guglielmo Ronco, Pamela Mancuso, Francesca Carozzi, Elena Allia, Raffaella Rizzolo, Daniela Gustinucci, Helena Frayle, Jessica Viti, Anna Iossa, Elena Cesarini, Simonetta Bulletti, Basilio Passamonti, Silvia Gori, Laura Toniolo, Francesco Venturelli, Annarosa Del Mistro, Paolo Giorgi Rossi, Maria Benevolo

    Published 2025-01-01
    “…ABSTRACT The use of clinically validated human papillomavirus (HPV) assays is recommended in cervical cancer screening, and extended genotyping is getting attention as a triage biomarker because of the different oncogenic risk of the high-risk HPV genotypes. …”
    Get full text
    Article
  5. 25
  6. 26

    [18F]PARPi Imaging Is Not Affected by HPV Status In Vitro by Navjot Guru, Paula Demétrio De Souza França, Giacomo Pirovano, Cien Huang, Snehal G. Patel, Thomas Reiner

    Published 2021-01-01
    “…Human papillomavirus- (HPV-) associated oropharyngeal squamous cell carcinomas (OPSCCs) are clinically and pathologically distinct from HPV-negative tumors. …”
    Get full text
    Article
  7. 27
  8. 28
  9. 29
  10. 30
  11. 31

    Analysis of HPV genotype differences in different stages of cervical intraepithelial neoplasia by YU Jingmin, CHEN Yan, YANG Xuewen

    Published 2024-11-01
    “…The influencing factors of CIN progression were analyzed, and HPV genotyping was performed logistic regression analysis was used to examine relationship between HPV genotypes and the degree of CIN progression, and the interaction between HPV genotypes and CIN progression-related factors were assessed.ResultsHPV genotype analysis revealed that HPV16, HPV58, HPV18, and HPV52 were the most common genotypes among CIN patients. …”
    Get full text
    Article
  12. 32

    Advancing the Fight Against Cervical Cancer: The Promise of Therapeutic HPV Vaccines by Qian Zheng, Misi He, Zejia Mao, Yue Huang, Xiuying Li, Ling Long, Mingfang Guo, Dongling Zou

    Published 2025-01-01
    “…Human papillomavirus (HPV) is a major global health issue and is recognized as the leading cause of cervical cancer. …”
    Get full text
    Article
  13. 33
  14. 34

    Malignant Transformation of Temporal Bone Schneiderian Papilloma Associated with HPV-6 by O. Marzouk, F. Brasch, I. Todt, P. K. C. Goon, H. Sudhoff

    Published 2021-01-01
    “…To report a novel case of a malignant transformation of TBSP associated with HPV-6 and to present its management. Case Report. …”
    Get full text
    Article
  15. 35

    A Very Rare Case: HPV-Negative Vulvar Cancer in an Adolescent by Ilker Kahramanoglu, Hasan Turan, Yahya Ozgun Oner, Tugan Bese, Sennur Ilvan, Macit Arvas, Fuat Demirkiran

    Published 2018-01-01
    “…These patients have usually risk factors such as human papillomavirus (HPV) infection and immunosuppression. Herein, we present a case of invasive squamous vulvar cancer in an 18-year-old patient without any risk factor. …”
    Get full text
    Article
  16. 36
  17. 37

    Effects of different-valent vaccines against human papillomavirus (HPV) to prevent persistent HPV16/18 infections and CIN2+ in women: a systematic review and network meta-analysis by Haiyue Wu, Lucia Li, Kun Fu, YuFei Shen, Yingnan Lu, Zexi Liao, Yingzhen Liu, Wenting Zha, Lisha Wu, Yu Zhang

    Published 2025-02-01
    “…Objectives: To evaluate the efficacy of 2-valent, 4-valent and 9-valent HPV vaccination in preventing persistent HPV infections and cervical intraepithelial neoplasia grade 2 or higher (CIN2+) lesions among women with different infection statuses at baseline. …”
    Get full text
    Article
  18. 38

    A comparative analysis of clinicopathological features of HPV-associated and HPV-independent cervical carcinomas based on P16 INK4a immunohistochemistry: A one-year retrospective study by Padmavathi D. Chaganti, Kaumudi Konkay, Ann M. Varghese

    Published 2023-07-01
    “…The recent WHO classification of female genital tracts recommends cervical carcinomas to be further subtyped as HPV-associated and HPV-independent and accepted p16 immunoreactivity as a surrogate biomarker for HPV testing. …”
    Get full text
    Article
  19. 39
  20. 40